Perspective on Nonsteroidal Mineralocorticoid Receptor Antagonism in Diabetic Kidney Disease

Jasleen K Ghuman; Katherine R Tuttle

doi:10.34067/KID.0007072021

Perspective on Nonsteroidal Mineralocorticoid Receptor Antagonism in Diabetic Kidney Disease

Kidney360. 2022 Jan 19;3(4):744-748. doi: 10.34067/KID.0007072021. eCollection 2022 Apr 28.

Authors

Jasleen K Ghuman¹, Katherine R Tuttle^{1

2

3}

Affiliations

¹ Division of Nephrology, University of Washington, Seattle, Washington.
² Division of Nephrology, University of Washington School of Medicine, Kidney Research Institute, and Institute of Translational Health Sciences, Seattle, Washington.
³ Providence Medical Research Center, Providence Health Care, Spokane, Washington.

No abstract available

Keywords: chronic kidney disease prevention; diabetes and the kidney; diabetic kidney disease; kidney health; nonsteroidal mineralocorticoid receptor antagonist.

MeSH terms

Diabetes Mellitus*
Diabetic Nephropathies* / drug therapy
Humans
Mineralocorticoid Receptor Antagonists / therapeutic use
Naphthyridines
Receptors, Mineralocorticoid / metabolism
Renin-Angiotensin System

Substances

Mineralocorticoid Receptor Antagonists
Naphthyridines
Receptors, Mineralocorticoid